Article

Ocular vitamin brand available through physicians, drug stores

In an effort to increase patient adherence to therapy and safety, as well as to maximize effectiveness, two eye-health products (Macular Health Formula and Dry Eye Formula, EyeScience) are sold to both eye-care professionals for resale from their offices and through a mass market retailer.

Columbus, OH

-In an effort to increase patient adherence to therapy and safety, as well as to maximize effectiveness, two eye-health products (Macular Health Formula and Dry Eye Formula, EyeScience) are sold to both eye-care professionals for resale from their offices and through a mass market retailer, according to the company. The company’s ocular vitamins are the only ones that are available through both channels, according to the company.

The program also is designed to improve accessibility to the company’s products. Once patients are educated in a practice about the benefits of using ocular vitamins, they either can purchase the product directly from the eye-care professional or go to any CVS pharmacy.

The age-related macular degeneration formula contains vitamin C, vitamin E, zinc, copper, selenium, vitamin B-6, folate, lutein, zeaxanthin, omega-3 fatty acids, bilberry, alpha-lipoic acid, grape seed extract, and L-glutathione. The formula for dry eye contains vitamin E, flaxseed oil, omega-3 fatty acids, vitamin B-6, magnesium, and lactoferrin.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.